SCHEMBL17832242

SCHEMBL17832242

O=Cc1cnc(N2CCC(Oc3ccc(OC(F)(F)F)cc3)C(F)C2)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.38
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
KCNH2 Q12809 10/20 0.38
NTRK1 P04629 8/20 0.38
NTRK3 Q16288 2/20 0.38
NTRK2 Q16620 2/20 0.38
ADRA1A P35348 1/20 0.38
FAAH O00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19627317 1.00 FFAR1 (0.38) FFAR1HDAC3HDAC4HDAC1HDAC7
SCHEMBL17832239 0.88 ACACB (0.39) FFAR1PDE3BPDE3AKCNH2NTRK1
SCHEMBL19627316 0.86 PDE3B (0.48) PDE3BPDE3AKCNH2FAAHEPHX2
SCHEMBL17832260 0.83 EPHX2 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17832257 0.79 SCN9A (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17832266 0.76 MAPT (0.43) FAAHEPHX2MCHR1
SCHEMBL17832326 0.76 KCNA5 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL19627318 0.75 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23636875 0.75 LIPG (0.49)
SCHEMBL17832206 0.74 ACACB (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016091207-A1 NITROMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN DRUG MANUFACTURING 上海阳帆医药科技有限公司 2016-06-16 WO disclosed